Widimsky J, Debinski W, Kuchel O, Buu N T
Laboratory of the Autonomic Nervous System, Clinical Research Institute of Montreal, Hôtel-Dieu Hospital, Québec, Canada.
Am J Physiol. 1990 Jan;258(1 Pt 2):H134-9. doi: 10.1152/ajpheart.1990.258.1.H134.
The disappearance of [125I]atrial natriuretic factor (ANF; Ser99-Tyr126) from the circulation and its tissue distribution with or without nonlabeled ANF pretreatment were investigated in normotensive Sprague-Dawley rats. Preadministration of the cold peptide increased plasma radioactivity levels for over 8 min following labeled ANF injection but did not change the half-life of circulating labeled ANF. The metabolic clearance rate (MCR) and volume of distribution in the first, second, and steady state phase were significantly decreased after cold ANF pretreatment. Circulating iodo-labeled ANF was taken up by several organs, even by tissues such as fat or bone, but its urinary excretion was very low. The highest uptake was found in the liver (16 +/- 1% of the injected dose), lung (14 +/- 1%), and kidney (12 +/- 1%), diminishing by 21, 89, and 59%, respectively, after cold ANF preinjection. The brain radioactivity was negligible implying an inability of [125I]ANF to cross the blood-brain barrier. Our data underscore the importance of the uptake-mediated, cold ANF preadministration suppressible clearance of ANF from the circulation, probably one of its basic elimination mechanisms. The liver, lung, and kidney are probably the most important participants in the MCR of ANF.
在正常血压的斯普拉格-道利大鼠中,研究了[125I]心房利钠因子(ANF;Ser99-Tyr126)在循环中的消失情况以及有无未标记ANF预处理时其在组织中的分布。注射标记的ANF后,预先给予冷肽可使血浆放射性水平在超过8分钟的时间内升高,但并未改变循环中标记ANF的半衰期。冷ANF预处理后,代谢清除率(MCR)以及第一、第二和稳态阶段的分布容积均显著降低。循环中的碘标记ANF被多个器官摄取,甚至包括脂肪或骨骼等组织,但其尿排泄量非常低。在肝脏(占注射剂量的16±1%)、肺(14±1%)和肾脏(12±1%)中摄取量最高,冷ANF预注射后,这些器官的摄取量分别减少了21%、89%和59%。脑放射性可忽略不计,这意味着[125I]ANF无法穿过血脑屏障。我们的数据强调了摄取介导的、冷ANF预给药可抑制的ANF从循环中清除的重要性,这可能是其基本消除机制之一。肝脏、肺和肾脏可能是ANF代谢清除率中最重要的参与器官。